Canopy Growth Corporation reported CAD 294M of revenue over the trailing twelve months, +6.8% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: CAD 294M (to Q1 2027). Net income: −CAD 233M, trailing twelve months to Q1 2027. Free cash flow: −CAD 83M, trailing twelve months to Q1 2027. Operating margin: −56%, trailing twelve months to Q1 2027.

CGCCanopy Growth Corporation

Healthcare

$0.85-42% 1Y

$0.85

$0.8552 weeks$1.92

Latest close: a new 52-week lowOct 8, 2026what changed →

CGC as reported

Canopy Growth Corporation reported CAD 294M of revenue over the trailing twelve months, +6.8% on the year before. 10 reported series are charted on this page, each one as filed.

CAD 294M

Revenue, trailing twelve months · to Q1 2027 · +6.8% against the twelve months before

Net income: −CAD 233M
Net income · −48% year on year · trailing twelve months to Q1 2027
Free cash flow: −CAD 83M
Free cash flow · −37% year on year · trailing twelve months to Q1 2027
Operating margin: −56%
Operating margin · trailing twelve months to Q1 2027

Details›

Every series Ryufin has for CGC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	CAD 294M	+6.8%	Q1 2027
Net income	−CAD 233M	−48%	Q1 2027
EPS	−CAD 0.70	−81%	Q1 2027
Gross margin	25%	n/a	Q1 2027
Operating margin	−56%	n/a	Q1 2027
Net margin	−80%	n/a	Q1 2027
ROE	−40%	n/a	Q1 2027
ROA	−26%	n/a	Q1 2027
ROIC	−16%	n/a	Q1 2027
Free cash flow	−CAD 83M	−37%	Q1 2027

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.